OP0351 First diagnosis of uveitis is not higher among juvenile idiopathic arthritis (JIA) patients receiving etanercept compared to methotrexate

• Published in: Annals of the rheumatic diseases Vol. 77; no. Suppl 2; pp. 221 - 222
• Main Authors: Davies, R., De Cock, D., Kearsley-Fleet, L., Ramanan, A., Hyrich, K.L.
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Limited 01.06.2018
• Subjects: Arthritis; Children; Diagnosis; Etanercept; Medical diagnosis; Methotrexate; Minority & ethnic groups; Morbidity; Patients; Population studies; Risk factors; Uveitis

BackgroundUveitis is a common comorbidity among patients with juvenile idiopathic arthritis (JIA), occurring in approximately 1 in 10 JIA patients. Among other risk factors such as early ageat JIA onset, shorter disease duration and oligoarticular subtype, the use of etanercept (ETN) may also increa...